Evonik Industries (FRA:EVK) has been given a €35.00 ($40.70) price target by analysts at Berenberg Bank in a research note issued on Wednesday. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective suggests a potential upside of 27.13% from the company’s current price.
EVK has been the topic of several other reports. Morgan Stanley set a €38.00 ($44.19) target price on Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, July 24th. Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. UBS Group set a €27.00 ($31.40) target price on Evonik Industries and gave the stock a “sell” rating in a research report on Monday, July 16th. Commerzbank set a €39.00 ($45.35) target price on Evonik Industries and gave the stock a “buy” rating in a research report on Monday, September 17th. Finally, Independent Research set a €34.00 ($39.53) target price on Evonik Industries and gave the stock a “neutral” rating in a research report on Tuesday, August 7th. Five equities research analysts have rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €34.48 ($40.09).
EVK stock traded up €0.48 ($0.56) during mid-day trading on Wednesday, hitting €27.53 ($32.01). The stock had a trading volume of 904,127 shares. Evonik Industries has a 1-year low of €26.78 ($31.14) and a 1-year high of €32.97 ($38.34).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: Using the New Google Finance Tool
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.